ERBB2 and breast carcinoma: We also applied immunoFISH for temporal analysis of HER2 mRNA and AKT1 mRNA expression, and phosphoAKT protein levels in HER2-positive breast cancer single cells treated with the HER-family tyrosine kinase inhibitor lapatinib.